藥物發現資訊學市場規模、佔有率、成長分析、按功能、按應用、按解決方案、按最終用戶、按地區 - 行業預測，2025 年至 2032 年

2023 年全球藥物發現資訊學市場規模價值 32.9 億美元，預計將從 2024 年的 36.6 億美元成長到 2032 年的 86.2 億美元，預測期內（2025-2032 年）的複合年成長率為 11.3%。

由於生物技術和製藥公司加大對研究的投入，以及對罕見疾病治療和罕見疾病藥物開發的需求不斷成長，全球藥物發現資訊學市場正在經歷顯著成長。研究支出的激增凸顯了資料管理在藥物研發中的關鍵作用，而廣泛的藥物和化合物資料庫對於藥物研究至關重要。現代資訊學受到高效能運算和線上服務的推動，採用先進的軟體進行有效的資料處理、管理和分析。此外，對藥物開發的日益關注、對新型治療藥物的需求不斷增加以及In Silico分析的廣泛使用進一步推動了市場擴張。然而，雖然與資訊工具相關的高成本可能會阻礙成長，開發中國家新興的生物技術領域仍存在著有利可圖的機會。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管分析
• 技術分析
• 專利分析

藥物發現資訊學市場規模（依功能分類）

• 市場概況
• 定序和目標資料分析
• 對接
• 分子建模
• 準備庫和資料庫
• 其他功能

藥物發現資訊學市場規模（按應用）

• 市場概況
• 藥物研發
• 藥物開發
  • 臨床前研究
  • 臨床試驗

藥物發現資訊學市場規模（按解決方案）

• 市場概況
• 軟體
• 服務

藥物發現資訊學市場規模（按最終用戶分類）

• 市場概況
• 製藥公司
• 生技公司
• 業務研究組織（CRO）
• 其他最終用戶

藥物發現資訊學市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• IBM（United States）
• Infosys Limited（India）
• Thermo Fisher Scientific（United States）
• PerkinElmer Inc.（United States）
• Schrodinger, Inc.（United States）
• Charles River Laboratories International, Inc.（United States）
• Certara, Inc.（United States）
• Accenture plc（Ireland）
• Agilent Technologies, Inc.（United States）
• Illumina, Inc.（United States）
• Dassault Systemes SE（France）
• Collaborative Drug Discovery, Inc.（United States）
• Eurofins DiscoverX Products（United States）
• Jubilant Biosys Limited（India）
• Selvita SA（Poland）
• Novo Informatics Pvt. Ltd.（India）
• ChemAxon Ltd.（Hungary）
• Albany Molecular Research Inc.（United States）
• Boehringer Ingelheim GmbH（Germany）
• Oracle Corporation（United States）

結論和建議

Global Drug Discovery Informatics Market size was valued at USD 3.29 billion in 2023 and is poised to grow from USD 3.66 billion in 2024 to USD 8.62 billion by 2032, growing at a CAGR of 11.3% during the forecast period (2025-2032).

The global drug discovery informatics market is witnessing significant growth driven by rising demand for rare illness treatments and orphan drug development, alongside enhanced research investment by biotechnology and pharmaceutical companies. This surge in research expenditure highlights the vital role of data management in drug discovery, where extensive databases of drugs and compounds are essential for pharmaceutical research. Modern informatics employs advanced software for effective data processing, management, and analysis, supported by improvements in high-performance computing and online services. Additionally, the growing focus on drug development, increasing need for new therapeutics, and widespread adoption of in silico modeling technology further propel market expansion. However, the high costs associated with informatics tools may hinder growth, while emerging biotech sectors in developing nations present lucrative opportunities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Drug Discovery Informatics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Drug Discovery Informatics Market Segments Analysis

Global Drug Discovery Informatics Market is segmented by Function, Application, Solution, End User and region. Based on Function, the market is segmented into Sequencing and Target Data Analysis, Docking, Molecular Modelling, Library & Database Preparation and Other functions. Based on Application, the market is segmented into Drug Discovery and Drug Development. Based on Solution, the market is segmented into Software and Services. Based on End User, the market is segmented into Pharmaceutical Companies, Biotechnology Companies, Contract Research Organization (CROs) and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Drug Discovery Informatics Market

The global drug discovery informatics market is significantly propelled by the swift developments in technology, especially in artificial intelligence (AI) and machine learning (ML). These innovations enhance data analysis capabilities, enabling researchers to process vast amounts of information swiftly and accurately. This increased efficiency not only streamlines the identification of molecular candidates for drug development but also expedites the overall drug discovery process. By harnessing powerful algorithms and predictive analytics, AI and ML are revolutionizing how pharmaceutical companies approach drug development, thereby driving the growth of the drug discovery informatics market on a global scale.

Restraints in the Global Drug Discovery Informatics Market

The Global Drug Discovery Informatics market faces significant obstacles due to concerns surrounding data protection and the necessity to adhere to legal regulations. Compliance with privacy laws, such as the General Data Protection Regulation (GDPR), complicates the management and sharing of critical information. As a result, these regulatory challenges hinder research efforts and create barriers that limit the adoption of advanced informatics technologies by companies. Consequently, this situation stifles innovation and growth within the market, making it increasingly difficult for organizations to leverage new insights and capabilities essential for advancing drug discovery processes on a global scale.

Market Trends of the Global Drug Discovery Informatics Market

The Global Drug Discovery Informatics market is witnessing a significant trend towards the increasing adoption of artificial intelligence (AI) and machine learning (ML) technologies. This shift is revolutionizing the industry by enhancing data analysis capabilities, expediting the identification of potential drug candidates, and leveraging predictive modeling to streamline the drug discovery process. As a result, pharmaceutical companies and research institutions are experiencing heightened creativity and operational efficiency, driving the demand for advanced informatics solutions. This trend indicates a transformative approach to drug discovery, promising more innovative therapies and faster time-to-market, thus positioning AI and ML as pivotal elements in the future of pharmacological research.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Technology Analysis
• Patent Analysis

Global Drug Discovery Informatics Market Size by Function & CAGR (2025-2032)

• Market Overview
• Sequencing and Target Data Analysis
• Docking
• Molecular Modelling
• Library & Database Preparation
• Other functions

Global Drug Discovery Informatics Market Size by Application & CAGR (2025-2032)

• Market Overview
• Drug Discovery
• Drug Development
  • Preclinical Testing
  • Clinical Trials

Global Drug Discovery Informatics Market Size by Solution & CAGR (2025-2032)

• Market Overview
• Software
• Services

Global Drug Discovery Informatics Market Size by End User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical Companies
• Biotechnology Companies
• Contract Research Organization (CROs)
• Other End Users

Global Drug Discovery Informatics Market Size & CAGR (2025-2032)

• North America (Function, Application, Solution, End User)
  • US
  • Canada
• Europe (Function, Application, Solution, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Function, Application, Solution, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Function, Application, Solution, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Function, Application, Solution, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• IBM (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Infosys Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Schrodinger, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories International, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Certara, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Accenture plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dassault Systemes SE (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Collaborative Drug Discovery, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins DiscoverX Products (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jubilant Biosys Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Selvita S.A. (Poland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novo Informatics Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ChemAxon Ltd. (Hungary)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Albany Molecular Research Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oracle Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations